moclobemide has been researched along with Central Nervous System Disease in 3 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benazzi, F | 1 |
| Gillman, PK | 1 |
| Dardennes, RM | 1 |
| Even, C | 1 |
| Ballon, N | 1 |
| Bange, F | 1 |
3 other studies available for moclobemide and Central Nervous System Disease
| Article | Year |
|---|---|
Serotonin syndrome with moclobemide-fluoxetine combination.
Topics: Adult; Benzamides; Central Nervous System Diseases; Drug Therapy, Combination; Female; Fluoxetine; H | 1996 |
Serotonin syndrome--clomipramine too soon after moclobemide?
Topics: Adult; Benzamides; Central Nervous System Diseases; Clomipramine; Depressive Disorder; Drug Interact | 1997 |
Serotonin syndrome caused by a clomipramine-moclobemide interaction.
Topics: Adult; Benzamides; Central Nervous System Diseases; Clomipramine; Confusion; Drug Interactions; Fema | 1998 |